Recently, a case involving the death of a stroke patient due to contrast agent extravasation during a medical imaging procedure has drawn public attention. Contrast agents are commonly used in CT scans or angiography to enhance image clarity and help clinicians better visualize blood vessels and tissues. However, in rare instances, the contrast medium may leak outside the blood vessels—known as extravasation—due to improper injection technique, vascular injury, or patient-specific factors such as severe arteriosclerosis or coagulation disorders. While minor extravasation typically causes only localized swelling or discomfort, significant leakage can lead to tissue necrosis, acute inflammatory responses, and even multi-organ failure, potentially resulting in death. Elderly patients, those with impaired kidney function, or individuals with multiple comorbidities (such as stroke survivors) face higher risks. Healthcare providers must rigorously assess patient eligibility, adhere to standardized protocols, and maintain emergency response plans. Immediate actions upon extravasation include halting the injection, elevating the affected limb, applying cold compresses, and closely monitoring vital signs. This incident underscores the critical need to balance diagnostic precision with patient safety and individualized risk assessment.
近日，一则关于脑梗患者在进行医学影像检查过程中因造影剂外溢导致死亡的事件引发公众关注。造影剂常用于CT或血管造影等检查，以增强图像对比度，帮助医生更清晰地观察血管和组织结构。然而，在极少数情况下，造影剂可能因注射技术不当、血管损伤或患者个体差异（如严重血管硬化、凝血功能障碍）而发生外溢，即渗漏至血管外组织。轻度外溢通常仅引起局部肿胀或疼痛，但若大量造影剂渗入周围组织，可能造成组织坏死、急性炎症反应，甚至诱发多器官功能衰竭，危及生命。尤其对于高龄、肾功能不全或基础疾病较多的脑梗患者，风险更高。医疗机构应严格评估患者适应症，规范操作流程，并配备应急处理预案。一旦发生外溢，需立即停止注射、抬高患肢、冷敷并密切监测生命体征。此事件提醒我们，在追求精准诊断的同时，必须高度重视医疗安全与个体化风险评估。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/8948.html